<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Meet the 2020 On-site Team

Meet some of the people who help keep our wheels turning (literally and figuratively).

Our Board of Directors


Alexis McLaughlin

Alexis has spent over 20 years developing and transforming brands to achieve breakthrough results, consumer intimacy and competitive advantage. Prior to joining 2020 On-site as CEO, Alexis helped to transform the vision care market by doubling the Target Optical business while delivering industry leading NPS, customer retention and employee engagement.  She is a passionate brand builder who honed her marketing chops on much-loved brands like Total cereal, Progresso soup, Betty Crocker and Cheerios.  Alexis intimately understands specialty retail, consumer experience and brand love and hopes to transform the vision care experience to be personalized, fun and easy.  

Outside of work, Alexis enjoys spending time with her husband and son, including travel to their favorite destinations – Italy, Lake Champlain Islands and BVI.  Ironically, Alexis didn’t have her first eye exam until she was 36!


Howard Bornstein

Howard is a Board Member and the Founder of 2020 On-site.  He is an investor and entrepreneur focused on tech and healthcare.  Howard is an Advisor to Pliant.io, a self-serve integration and process automation platform for infrastructure software.  He was previously a Board Member of Serraview Inc., an integrated workforce management SaaS company which sold to JMI in 2018, as well as an investor at Bain Capital Ventures and Bain Capital Private Equity.  Howard holds a Bachelor of Arts from the University of Western Ontario and a Master of Business Administration and Masters of Public Policy from Stanford University.


RoAnn Costin

RoAnn Costin is the founder and president of Wilderness Point Investments, a private equity company that focuses on investing in early and expansion stage consumer non-durable product and retailing companies. Ventures in which Ms. Costin has invested and sits or has sat on the board of directors include Lululemon Athletica, Genuine Health International, 2020 Onsite Optometry and Sarah Flint, Inc.  Ms. Costin began her career in 1981 working for State Street Research and Management, Co. She was the first woman investment analyst, portfolio manager and partner in the firm.  Ms. Costin joined the Putnam Companies as a member of the Quality Growth group, and was President of Reservoir Capital Management, a firm specializing in quality growth equities investments.  Ms. Costin worked in government at the federal and local levels. She received an MBA from Stanford University and a BA in Government, cum laude, from Harvard University, where she was an All-American in swimming and rowing. She currently serves on the Board of Trustees for Stanford University, Isabella Stewart Gardner Museum, Perkins School, American Repertory Theater and Codman Academy Charter School.


Dylan Hardy

Dylan is an entrepreneurial leader with proven experience in founding, building, and scaling innovative firms that solve real-world problems.   His areas of focus are accelerating sales, scaling operations and improving quality.

He is the founder of Victor Avenue Capital, an investment firm that partners with entrepreneurs in the technology and healthcare sectors to provide the capital and advice required to grow their business.   Prior to launching VAC, Dylan was a partner in KPMG’s strategy and operations practice working with clients in the US, Canada and Asia. Before his time at KPMG, Dylan was a co-founder of HIO Group and a consultant with McKinsey & Company.


Stephanie Monaghan O’Brien, J.D.

Stephanie O’Brien has been a member of the Morningside investment team since 1997, working with venture-backed companies focused on novel science. Ms. O’Brien has been a director of numerous companies developing drugs across a broad spectrum of therapeutic areas, including oncology and immunotherapy, and has extensive experience providing operational and management guidance to rapidly growing life science and technology companies. She has served on public and private company boards, including Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Aduro Biotech, Inc.(NASDAQ:ADRO), I-Behavior, Inc., Canopy Education, Inc., Natural Polymer International Corp., Linc Global, Inc., Vioptix, Inc., and Vigeo Therapeutics, Inc.

Ms. O’Brien has also worked on M&A deals and financings for public and private companies such as DNAtrix, Inc., Dendreon Corporation, BioVex Group, Inc., Stealth Biotherapeutics Inc. and Sohu.com. Prior to Morningside, Ms. O’Brien spent nine years as a corporate lawyer with Hale and Dorr in the Boston and Washington, D.C. offices, working primarily with venture capital finance and start-up companies. She received her A.B., cum laude, from Harvard College and her J.D. from New York University School of Law.


Anthony Morris

Tony Morris is an IT and internet entrepreneur, investor, Board Director, and consultant providing strategy and venture development advice to technology-based growth companies and investors.  He has made 30 direct investments in private companies and is an LP in US and European VC and private equity firms.  In 1980 Tony founded Morris Decision Systems, a pioneering PC reseller and network systems integrator in New York, ranking #9 on the Inc. 500 when sold.  He has been profiled as a successful investor in Winning Angels by Harvard Business School’s Howard Stevenson and David Amis and Raising Venture Capital Finance in Europe by Keith Arundale.  Tony has an AB from the University of Pennsylvania and an MBA from Stanford University.  He participates in the Dean’s Council at the Harvard Kennedy School.

Plans and Pricing

Subscribe to Our Blog  Don't miss out on insightful updates on wellness, eye health, and glasses  fashion from our blog, Hindsight! Sign Up Now
How Does Your Wellness Program Stack Up?  The competition is tough. Use our new wellness calculator to gauge how you're  doing.  Benchmark Your Wellness
Get in Touch  If you have questions or would like to speak to our team, we'd love to hear  from you! Contact Us